Ultracef
Ultracef Brand names, Ultracef Analogs
Ultracef Brand Names Mixture
- None
Ultracef Chemical_Formula
C16H17N3O5S
Ultracef RX_link
http://www.rxlist.com/cgi/generic/cefadrox.htm
Ultracef fda sheet
Ultracef msds (material safety sheet)
Ultracef Synthesis Reference
L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)
Ultracef Molecular Weight
363.389 g/mol
Ultracef Melting Point
197oC
Ultracef H2O Solubility
1110 mg/L
Ultracef State
Solid
Ultracef LogP
-0.355
Ultracef Dosage Forms
Capsule; Tablet; Oral liquid
Ultracef Indication
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
Ultracef Pharmacology
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Ultracef Absorption
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.
Ultracef side effects and Toxicity
Nausea, vomiting, diarrhoea, allergic rashes may occur
Ultracef Patient Information
Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.
Ultracef Organisms Affected
Enteric bacteria and other eubacteria
